News & Resources

Press Release

Printer Friendly Version View printer-friendly version
<< Back
Orexigen Therapeutics to Provide Business Update and Discuss Third Quarter 2017 Financial Results on November 13, 2017

SAN DIEGO, Oct. 31, 2017 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) will announce corporate and financial results for the third quarter of 2017 on Monday, November 13th after the market closes.  Following the announcement, Orexigen will provide a business update and discuss the financial results in a live webcast and conference call at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).

The live call may be accessed by phone by calling (800) 708-4539 (domestic) or (847) 619-6396 (international), participant code 45886353.  The webcast can be accessed live on the "Investors" section of the Orexigen web site at www.orexigen.com, and will be archived for 14 days following the call.

Orexigen Contact:
Jason Keyes
Chief Financial Officer
Orexigen Therapeutics, Inc.
+1-858-875-8600
jkeyes@orexigen.com

Media Contact:
Erika Hackmann
Y&R
+1-917-538-3375
erika.hackmann@yr.com

 

View original content:http://www.prnewswire.com/news-releases/orexigen-therapeutics-to-provide-business-update-and-discuss-third-quarter-2017-financial-results-on-november-13-2017-300546934.html

SOURCE Orexigen Therapeutics, Inc.